AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF
FEBU · ETF
About FEBU
- Issuer
- Allianz
- Expense ratio
- 0.74%
- Assets under management
- $52.24M
- Inception
- Jan 31, 2025
- Asset class
- Alternatives
- Website
- allianzimetfs.com
FEBU key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 3.01K
- Volume
- 1.51K
- Open price
- $29.98
- High today
- $29.92
- Low today
- $29.86
- 52 Week high
- $30.62
- 52 Week low
- $26.52
AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF (FEBU) at a glance
As of Oct 23, 2026, AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF (FEBU) shares are priced at $29.86, giving the company a price-to-earnings ratio of 0.00.
Today the fund has traded between $29.86 and $29.92. The current price is 0.0% above the day's low and 0.2% below its high.
Volume so far is 1.51K shares, below the average of 3.01K shares a day.
Over the past year AllianzIM U.S. Equity Buffer15 Uncapped Feb ETF has ranged from $26.52 to $30.62, and now sits 82% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.